A Detailed Analysis of Hepatitis C Virus (HCV) Testing Market by Immunoassays-based Hepatitis C Virus Testing, Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing, and Other Hepatitis C Virus Testing Techniques
Interested in exploring key trends and breakthroughs in Hepatitis C Virus (HCV) Testing? FMI presents its exhaustive findings on the subject
Hepatitis C Virus (HCV) Testing Market Outlook (2023 to 2033)
The global hepatitis C virus (HCV) testing market size is expected to accumulate US$ 785.3 million in value by 2023 end. During the forecast period ranging from 2023 to 2033, a CAGR worth 5.4% has been projected for the market, with an expected closing value worth US$ 1,326.7 million. From 2018 to 2022, the industry unfolded at a value CAGR worth 4.6%.
The growing burden of infectious diseases on the global healthcare system is a significant consideration, with developing countries bearing a disproportionate share of the burden. Over time, the burden of hepatitis C virus infection has accelerated. According to the Institute of Liver and Biliary Sciences India, around 3% of the world's population is infected with the hepatitis C virus.
In 80 percent of infected patients, HCV did cause chronic infection. Initial hepatitis C virus testing employs serological assays to detect antibodies against HCV in blood samples. According to the Centers for Disease Control and Prevention (CDC) guidelines for hepatitis C screening, a cut-off ratio for anti-HPV antibodies is added, which aids in the selection of additional assays for confirmation of screening results.
The Nucleic Acid Amplification Test (NAT) is used to confirm and determine viral load. Regarding all constructive HCV antibody tests, an RNA test is performed. HCV genotyping tests are used in clinical HPV management to determine viral load and optimal treatment duration. Also, the use of non-sterile needles for tattooing and body piercing is a common cause of hepatitis C virus infection spread.
Attributes
Key Statistics
Global Market CAGR (2023 to 2033)
5.4%
Anticipated Market Value (2023)
US$ 785.3 million
Global Market (2033)
US$ 1,326.7 million
Global Market Attraction
The rising prevalence of hepatitis C virus infection fueled by inadequate blood donation strategies
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Factors Spearheading the Global Hepatitis C Virus (HCV) Testing Market
The rising prevalence of hepatitis C virus infection is the primary driver of the global hepatitis C virus testing market. Inadequate blood donation strategies are the leading cause of hepatitis C virus infection. Also, hepatitis C screening is required before organ donation, and growing organ donation projects around the world are expected to drive future growth.
The introduction of point-of-care testing products for HCV testing raises the potential for HCV testing kits. The FDA approved the OraQuick HCV Rapid Antibody Test in 2010, and it is now widely used as an alternative to enzyme immunoassay testing for HCV. Also, the use of new electrochemical immuno-sensor and nano-sensor technologies in HPV testing is expected to change current practices.
Factors Stunting the Global Hepatitis C Virus (HCV) Testing Market
Factors that are limiting the adoption of hepatitis C virus testing include:
Insufficient insurance coverage for hepatitis C testing
Find your sweet spots for generating winning opportunities in this market.
North America Emerging as an Opportunistic Hepatitis C Virus (HCV) Testing Market
Country/ Region
Market Share (2022)
North America
33.4%
The United States
29.5%
An estimated 12.5-40% of detained people in North America have HCV-antibody positivity, supporting the recommendation to screen this population for HCV infection and increasing market demand.
Infection with the Hepatitis C virus (HCV) is a leading cause of morbidity and mortality in the United States. HCV is primarily transmitted via parenteral exposure to infectious blood or body fluids containing blood, most commonly through injection drug use. With 8-12 weeks of all-oral medication regimens, direct-acting antiviral treatment can result in a virologic cure in most people. This factor is increasing market demand in North America.
HCV infection rates nearly doubled among women with live births in North America between 2009 and 2014, as new HCV infections increased among reproductive-aged adults. As a result, this factor is expected to drive market growth in this region. As per Future Market Insights, North America is likely to account for more than 33.4% of the global Hepatitis C virus testing market in 2023.
Demand for Hepatitis C Virus (HCV) Testing Burgeoning in Europe
Attribute
Details
Europe’s Market Share (2022)
30.7%
Germany’s Market Share (2022)
10%
The United Kingdom’s Forecast CAGR (2023 to 2033)
5.7%
In 2023, Europe is forecasted to account for more than 30.7% share in the hepatitis C virus testing market, and is projected to maintain this growth throughout the forecast period, states Future Market Insights.
According to a research paper published in the medical journal BMJ Open in August 2020, HCV diagnosis rates in Germany are projected to exceed 70% by 2030 under the current approach. Such encouraging trends in HCV testing in the country are expected to significantly aid market growth during the forecast period.
In Europe, Hepatitis C is one of the most common infectious diseases. Several initiatives in the region have been inaugurated to better understand disease trends, such as prevalence and the most widely known genotypes. It is a liver disease caused by the hepatitis C virus (HCV), and it can contribute to the development of liver cancer if left untreated.
Germany has historically had a low prevalence of hepatitis C than developing countries. However, the country's demographics have changed in recent years. Also, the increasing influx of migrants and rising drug abuse through injections among the general population are projected to augment the country's hepatitis C prevalence.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Start-ups Adding Value to the Global Market
The swelling dispersion of start-ups in the hepatitis C virus testing market has improved product quality and elevated global sales. Besides, to gain a competitive edge, new start-ups are working on novel developments and launching new products. Moreover, some notable players offering hepatitis C virus testing kits are as follows:
Start-up’s Name
Product in Detail
NATSpert
NATSpert, established in 2017 in Pune, India, is a developer of blood detection kits for viral diseases. Its product- NATSpert ID TripleH is a qualitative, real-time PCR test for the simultaneous detection of HIV, HBV, and HCV respectively. The kit comes in a single tube format and allows for screening of HIV type 1 group M-RNA, HIV-1 group-O RNA, HIV-2 RNA, Hepatitis C Virus RNA, and Hepatitis B Virus DNA in human blood plasma.
HepC
Founded in 2005, HepC is a developer of antiviral biologic products. The company deploys IBDV, a non-pathogenic double-stranded RNA virus. This virus acts as a master activator of antiviral gene responses as its primary vector system. Its product development includes HC001 for treating advanced chronic viral hepatitis caused by HBV and HCV infections.
Key Players Leading the Hepatitis C Virus Testing Marketplace
Some of the manufacturers identified in the global hepatitis C virus testing market include OraSure Technologies, Inc., Abbott Laboratories Inc., Siemens Healthcare GmbH, Bio Rad Laboratories Inc., Ortho Clinical Diagnostic Inc. (Johnson & Johnson), Bayer AG, QIAGEN N.V., Thermo Fisher Scientific Inc., BioGenex, AccuQuick, Roche Diagnostics (H. Hoffman-La Roche Ltd.), STD Rapid Test Kits, etc. among others.
Discover Recent Occurrences Shaping the Market
Organization’s Name
Roche
Nature of Development
Roche releases Novel Hepatitis C Virus Diagnostic test.
Key Particulars About the Event
Roche has introduced a new dual antibody and antigen diagnostic testing called Elecys HCV Duo immunoassay to treat the hepatitis C virus. The test is launched in countries that permit the CE Mark.
Organization’s Name
WHO and the University of BRISTOL
Nature of Development
WHO Collaborated with the University of BRISTOL to lead the research related to HCV.
Key Particulars About the Event
A new study exhibits the advantages of a quick clinic-based diagnostic test for HCV infection over a general laboratory-based test. The discoveries from the study have resulted in the WHO recommending the adoption of the point-of-care (POC) HCV test. These rapid tests make HCV diagnosis close and accessible to the community.
Organization’s Name
Mylab
Nature of Development
Pune’s Mylab Introduces Rapid Test Kits to rapidly Detect HCV, HIV, and Syphilis.
Key Particulars About the Event
Mylab Discovery Solutions, a Pune-based company, announced in February 2023, that it is releasing three new rapid tests to quickly detect STIs. STIs pose a grave hurdle as WHO predicts that the caseload of STIs is going to reach 1 million/day, globally.
Organization’s Name
J MITRA
Nature of Development
J MITRA releases 4th Gen Elisa-based HCV Test.
Key Particulars About the Event
In September 2022, J Mitra, which is an IVD Company, introduced the HCV Gen 4 Ag & Ab Microlisa, which is a 4th generation Elisa-based HCV Test. The kit aims to screen blood donations to detect and discard infection units of blood. The kit is also used as a clinical diagnostic test for Hepatitis C.
Organization’s Name
Access Bio Inc. and Atomo Diagnostics
Nature of Development
Access Bio Inc. and Atomo Diagnostics revealed the development of RDT.
Key Particulars About the Event
Access Bio Inc. and Atomo Diagnostics announced the development of a rapid diagnostic test (RDT) for screening for the hepatitis C virus in April 2019. (HCV). The tests were commercially available by the end of this year 2019.
Organization’s Name
Gilead Sciences Inc.
Nature of Development
Gilead Sciences Inc. reported the HepConnect Initiative.
Key Particulars About the Event
Gilead Sciences Inc. announced the HepConnect initiative to reduce hepatitis C infections in Great Appalachia in March 2019.
Report Scope
Report Attributes
Details
Growth Rate
CAGR of 5.4% from 2023 to 2033
Market Value in 2023
US$ 785.3 million
Market Value in 2033
US$ 1,326.7 million
Base Year for Estimation
2022
Historical Period
2018 to 2022
Forecast Period
2023 to 2033
Quantitative Units
Revenue in US$ million and CAGR from 2023 to 2033
Report Coverage
Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
Technique
End User
Test Type
Region
Regions Covered
North America
Latin America
Europe
Asia Pacific
The Middle East and Africa
Key Countries Profiled
The United States
Canada
Brazil
Mexico
Germany
The United Kingdom
France
Spain
Italy
China
Japan
South Korea
Malaysia
Singapore
Australia
New Zealand
GCC Countries
South Africa
Israel
Key Companies Profiled
OraSure Technologies, Inc.
Abbott Laboratories Inc.
Siemens Healthcare GmbH
Bio Rad Laboratories Inc.
Ortho Clinical Diagnostic Inc. (Johnson & Johnson)
Bayer AG
QIAGEN N.V.
Thermo Fisher Scientific Inc.
BioGenex
AccuQuick,
Roche Diagnostics (F. Hoffman-La Roche Ltd.)
STD Rapid Test Kits
Customization
Available Upon Request
Key Segments Covered in the Hepatitis C Virus (HCV) Testing Market Survey
By Technique:
Immunoassays-based Hepatitis C Virus Testing
Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
Other Hepatitis C Virus Testing Techniques
By Test Type:
HCV Antibody Testing
HCV Viral Load Testing
HCV Genotyping Testing
By End User:
Hospitals
Diagnostic Centers
Blood Donation Centers
By Region:
North America
Latin America
Europe
Asia Pacific
The Middle East & Africa
Frequently Asked Questions
How Big will the the Hepatitis C Virus (HCV) Testing Market?
This market is estimated to reach US$ 1,326.7 million by 2033.
What is North America’s Market Growth Outlook?
North America expanded at a market share of 33.4% in 2022.
What Restrains the Market Growth?
Limited access to regular healthcare restrains the market growth.
Which is the Top Driver in the Market?
Infectious diseases drive sales, hitting global healthcare and developing nations.
Which Region holds Lucrative Opportunities?
North America holds a substantial share of the market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technique
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Technique, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technique, 2023 to 2033
5.3.1. Immunoassays-based Hepatitis C Virus Testing
5.3.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
5.3.3. Other Hepatitis C Virus Testing Techniques
5.4. Y-o-Y Growth Trend Analysis By Technique, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Technique, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2023 to 2033
6.3.1. HCV Antibody Testing
6.3.2. HCV Viral Load Testing
6.3.3. HCV Genotyping Testing
6.4. Y-o-Y Growth Trend Analysis By Test Type, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Test Type, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033
7.3.1. Hepatitis C Virus Testing in Hospitals
7.3.2. Hepatitis C Virus Testing in Diagnostic Centers
7.3.3. Hepatitis C Virus Testing in Blood Donation Centers
7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Technique
9.2.3. By Test Type
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Technique
9.3.3. By Test Type
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Technique
10.2.3. By Test Type
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Technique
10.3.3. By Test Type
10.3.4. By End User
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Technique
11.2.3. By Test Type
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Technique
11.3.3. By Test Type
11.3.4. By End User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Technique
12.2.3. By Test Type
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Technique
12.3.3. By Test Type
12.3.4. By End User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Technique
13.2.3. By Test Type
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Technique
13.3.3. By Test Type
13.3.4. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Technique
14.2.3. By Test Type
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Technique
14.3.3. By Test Type
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Technique
15.2.3. By Test Type
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Technique
15.3.3. By Test Type
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Technique
16.1.2.2. By Test Type
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Technique
16.2.2.2. By Test Type
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Technique
16.3.2.2. By Test Type
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Technique
16.4.2.2. By Test Type
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Technique
16.5.2.2. By Test Type
16.5.2.3. By End User
16.6. UK
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Technique
16.6.2.2. By Test Type
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Technique
16.7.2.2. By Test Type
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Technique
16.8.2.2. By Test Type
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Technique
16.9.2.2. By Test Type
16.9.2.3. By End User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Technique
16.10.2.2. By Test Type
16.10.2.3. By End User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Technique
16.11.2.2. By Test Type
16.11.2.3. By End User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Technique
16.12.2.2. By Test Type
16.12.2.3. By End User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Technique
16.13.2.2. By Test Type
16.13.2.3. By End User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Technique
16.14.2.2. By Test Type
16.14.2.3. By End User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Technique
16.15.2.2. By Test Type
16.15.2.3. By End User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Technique
16.16.2.2. By Test Type
16.16.2.3. By End User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Technique
16.17.2.2. By Test Type
16.17.2.3. By End User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Technique
16.18.2.2. By Test Type
16.18.2.3. By End User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Technique
16.19.2.2. By Test Type
16.19.2.3. By End User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Technique
16.20.2.2. By Test Type
16.20.2.3. By End User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Technique
16.21.2.2. By Test Type
16.21.2.3. By End User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Technique
16.22.2.2. By Test Type
16.22.2.3. By End User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Technique
16.23.2.2. By Test Type
16.23.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Technique
17.3.3. By Test Type
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. OraSure Technologies, Inc.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Abbott Laboratories Inc.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Siemens Healthcare GmbH
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Bio Rad Laboratories Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Ortho Clinical Diagnostic Inc. (Johnson & Johnson)
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Bayer AG
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. QIAGEN N.V.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Thermo Fisher Scientific Inc.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. BioGenex
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. AccuQuick,
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. Roche Diagnostics (F. Hoffman-La Roche Ltd.)
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.12. STD Rapid Test Kits
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
19. Assumptions & Acronyms Used20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Technique, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by Test Type, 2018 to 2033
Table 4: Global Market Value (US$ Million) Forecast by End User , 2018 to 2033
Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 6: North America Market Value (US$ Million) Forecast by Technique, 2018 to 2033
Table 7: North America Market Value (US$ Million) Forecast by Test Type, 2018 to 2033
Table 8: North America Market Value (US$ Million) Forecast by End User , 2018 to 2033
Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 10: Latin America Market Value (US$ Million) Forecast by Technique, 2018 to 2033
Table 11: Latin America Market Value (US$ Million) Forecast by Test Type, 2018 to 2033
Table 12: Latin America Market Value (US$ Million) Forecast by End User , 2018 to 2033
Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 14: Western Europe Market Value (US$ Million) Forecast by Technique, 2018 to 2033
Table 15: Western Europe Market Value (US$ Million) Forecast by Test Type, 2018 to 2033
Table 16: Western Europe Market Value (US$ Million) Forecast by End User , 2018 to 2033
Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 18: Eastern Europe Market Value (US$ Million) Forecast by Technique, 2018 to 2033
Table 19: Eastern Europe Market Value (US$ Million) Forecast by Test Type, 2018 to 2033
Table 20: Eastern Europe Market Value (US$ Million) Forecast by End User , 2018 to 2033
Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 22: South Asia and Pacific Market Value (US$ Million) Forecast by Technique, 2018 to 2033
Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Test Type, 2018 to 2033
Table 24: South Asia and Pacific Market Value (US$ Million) Forecast by End User , 2018 to 2033
Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 26: East Asia Market Value (US$ Million) Forecast by Technique, 2018 to 2033
Table 27: East Asia Market Value (US$ Million) Forecast by Test Type, 2018 to 2033
Table 28: East Asia Market Value (US$ Million) Forecast by End User , 2018 to 2033
Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Technique, 2018 to 2033
Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Test Type, 2018 to 2033
Table 32: Middle East and Africa Market Value (US$ Million) Forecast by End User , 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Technique, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by Test Type, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by End User , 2023 to 2033
Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 8: Global Market Value (US$ Million) Analysis by Technique, 2018 to 2033
Figure 9: Global Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033
Figure 10: Global Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033
Figure 11: Global Market Value (US$ Million) Analysis by Test Type, 2018 to 2033
Figure 12: Global Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033
Figure 13: Global Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033
Figure 14: Global Market Value (US$ Million) Analysis by End User , 2018 to 2033
Figure 15: Global Market Value Share (%) and BPS Analysis by End User , 2023 to 2033
Figure 16: Global Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033
Figure 17: Global Market Attractiveness by Technique, 2023 to 2033
Figure 18: Global Market Attractiveness by Test Type, 2023 to 2033
Figure 19: Global Market Attractiveness by End User , 2023 to 2033
Figure 20: Global Market Attractiveness by Region, 2023 to 2033
Figure 21: North America Market Value (US$ Million) by Technique, 2023 to 2033
Figure 22: North America Market Value (US$ Million) by Test Type, 2023 to 2033
Figure 23: North America Market Value (US$ Million) by End User , 2023 to 2033
Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 28: North America Market Value (US$ Million) Analysis by Technique, 2018 to 2033
Figure 29: North America Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033
Figure 30: North America Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033
Figure 31: North America Market Value (US$ Million) Analysis by Test Type, 2018 to 2033
Figure 32: North America Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033
Figure 33: North America Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033
Figure 34: North America Market Value (US$ Million) Analysis by End User , 2018 to 2033
Figure 35: North America Market Value Share (%) and BPS Analysis by End User , 2023 to 2033
Figure 36: North America Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033
Figure 37: North America Market Attractiveness by Technique, 2023 to 2033
Figure 38: North America Market Attractiveness by Test Type, 2023 to 2033
Figure 39: North America Market Attractiveness by End User , 2023 to 2033
Figure 40: North America Market Attractiveness by Country, 2023 to 2033
Figure 41: Latin America Market Value (US$ Million) by Technique, 2023 to 2033
Figure 42: Latin America Market Value (US$ Million) by Test Type, 2023 to 2033
Figure 43: Latin America Market Value (US$ Million) by End User , 2023 to 2033
Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 48: Latin America Market Value (US$ Million) Analysis by Technique, 2018 to 2033
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033
Figure 51: Latin America Market Value (US$ Million) Analysis by Test Type, 2018 to 2033
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033
Figure 54: Latin America Market Value (US$ Million) Analysis by End User , 2018 to 2033
Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User , 2023 to 2033
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033
Figure 57: Latin America Market Attractiveness by Technique, 2023 to 2033
Figure 58: Latin America Market Attractiveness by Test Type, 2023 to 2033
Figure 59: Latin America Market Attractiveness by End User , 2023 to 2033
Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 61: Western Europe Market Value (US$ Million) by Technique, 2023 to 2033
Figure 62: Western Europe Market Value (US$ Million) by Test Type, 2023 to 2033
Figure 63: Western Europe Market Value (US$ Million) by End User , 2023 to 2033
Figure 64: Western Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 68: Western Europe Market Value (US$ Million) Analysis by Technique, 2018 to 2033
Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033
Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033
Figure 71: Western Europe Market Value (US$ Million) Analysis by Test Type, 2018 to 2033
Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033
Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033
Figure 74: Western Europe Market Value (US$ Million) Analysis by End User , 2018 to 2033
Figure 75: Western Europe Market Value Share (%) and BPS Analysis by End User , 2023 to 2033
Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033
Figure 77: Western Europe Market Attractiveness by Technique, 2023 to 2033
Figure 78: Western Europe Market Attractiveness by Test Type, 2023 to 2033
Figure 79: Western Europe Market Attractiveness by End User , 2023 to 2033
Figure 80: Western Europe Market Attractiveness by Country, 2023 to 2033
Figure 81: Eastern Europe Market Value (US$ Million) by Technique, 2023 to 2033
Figure 82: Eastern Europe Market Value (US$ Million) by Test Type, 2023 to 2033
Figure 83: Eastern Europe Market Value (US$ Million) by End User , 2023 to 2033
Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Technique, 2018 to 2033
Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033
Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033
Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Test Type, 2018 to 2033
Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033
Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033
Figure 94: Eastern Europe Market Value (US$ Million) Analysis by End User , 2018 to 2033
Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by End User , 2023 to 2033
Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033
Figure 97: Eastern Europe Market Attractiveness by Technique, 2023 to 2033
Figure 98: Eastern Europe Market Attractiveness by Test Type, 2023 to 2033
Figure 99: Eastern Europe Market Attractiveness by End User , 2023 to 2033
Figure 100: Eastern Europe Market Attractiveness by Country, 2023 to 2033
Figure 101: South Asia and Pacific Market Value (US$ Million) by Technique, 2023 to 2033
Figure 102: South Asia and Pacific Market Value (US$ Million) by Test Type, 2023 to 2033
Figure 103: South Asia and Pacific Market Value (US$ Million) by End User , 2023 to 2033
Figure 104: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033
Figure 105: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 106: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 107: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 108: South Asia and Pacific Market Value (US$ Million) Analysis by Technique, 2018 to 2033
Figure 109: South Asia and Pacific Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033
Figure 110: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033
Figure 111: South Asia and Pacific Market Value (US$ Million) Analysis by Test Type, 2018 to 2033
Figure 112: South Asia and Pacific Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033
Figure 113: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033
Figure 114: South Asia and Pacific Market Value (US$ Million) Analysis by End User , 2018 to 2033
Figure 115: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User , 2023 to 2033
Figure 116: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033
Figure 117: South Asia and Pacific Market Attractiveness by Technique, 2023 to 2033
Figure 118: South Asia and Pacific Market Attractiveness by Test Type, 2023 to 2033
Figure 119: South Asia and Pacific Market Attractiveness by End User , 2023 to 2033
Figure 120: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033
Figure 121: East Asia Market Value (US$ Million) by Technique, 2023 to 2033
Figure 122: East Asia Market Value (US$ Million) by Test Type, 2023 to 2033
Figure 123: East Asia Market Value (US$ Million) by End User , 2023 to 2033
Figure 124: East Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 125: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 126: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 127: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 128: East Asia Market Value (US$ Million) Analysis by Technique, 2018 to 2033
Figure 129: East Asia Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033
Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033
Figure 131: East Asia Market Value (US$ Million) Analysis by Test Type, 2018 to 2033
Figure 132: East Asia Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033
Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033
Figure 134: East Asia Market Value (US$ Million) Analysis by End User , 2018 to 2033
Figure 135: East Asia Market Value Share (%) and BPS Analysis by End User , 2023 to 2033
Figure 136: East Asia Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033
Figure 137: East Asia Market Attractiveness by Technique, 2023 to 2033
Figure 138: East Asia Market Attractiveness by Test Type, 2023 to 2033
Figure 139: East Asia Market Attractiveness by End User , 2023 to 2033
Figure 140: East Asia Market Attractiveness by Country, 2023 to 2033
Figure 141: Middle East and Africa Market Value (US$ Million) by Technique, 2023 to 2033
Figure 142: Middle East and Africa Market Value (US$ Million) by Test Type, 2023 to 2033
Figure 143: Middle East and Africa Market Value (US$ Million) by End User , 2023 to 2033
Figure 144: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033
Figure 145: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 146: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 147: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 148: Middle East and Africa Market Value (US$ Million) Analysis by Technique, 2018 to 2033
Figure 149: Middle East and Africa Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033
Figure 150: Middle East and Africa Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033
Figure 151: Middle East and Africa Market Value (US$ Million) Analysis by Test Type, 2018 to 2033
Figure 152: Middle East and Africa Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033
Figure 153: Middle East and Africa Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033
Figure 154: Middle East and Africa Market Value (US$ Million) Analysis by End User , 2018 to 2033
Figure 155: Middle East and Africa Market Value Share (%) and BPS Analysis by End User , 2023 to 2033
Figure 156: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033
Figure 157: Middle East and Africa Market Attractiveness by Technique, 2023 to 2033
Figure 158: Middle East and Africa Market Attractiveness by Test Type, 2023 to 2033
Figure 159: Middle East and Africa Market Attractiveness by End User , 2023 to 2033
Figure 160: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
